Bm. Balsiger et al., Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity, MAYO CLIN P, 75(7), 2000, pp. 673-680
Citations number
47
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objective: To determine prospectively the results of Roux-en-Y gastric bypa
ss (RYGB) used as the primary weight-reducing operation in patients with me
dically complicated ("morbid") obesity. The RYGB procedure combines the adv
antages of a restrictive physiology (pouch of 10 mL) and a "dumping physiol
ogy" for high-energy liquids without requiring an externally reinforced (ba
nded) stoma,
Patients and Methods: Between April 1987 and December 1998, a total of 191
consecutive patients with morbid obesity (median weight, 138 kg [range, 91-
240 kg]; median body mass index, 49 kg/m(2) [range, 36-74 kg/m(2)]), all of
whom had directly weight-related morbidity, underwent RYGB and prospective
follow-up.
Results: Hospital mortality was 0.5% (1/191), and hospital morbidity occurr
ed in 10.5% (20/191), Good longterm weight loss was achieved, and patients
adapted well to the required new eating habits. The mean +/- SD weight loss
at 1 year after operation (113 patients) was 52+/-1 kg or 68%+/-2% of init
ial excess body weight. By 3 years postoperatively (74 patients), weight lo
ss was still 66%+/-2% of excess body weight. Overall, 53 (72%) of 74 patien
ts had achieved and maintained a weight loss of 50% or more of their preope
rative excess body weight 3 years after the operation. In addition, only 1
(1%) of 98 patients had persistent postoperative vomiting 1 or more times p
er week.
Conclusion: We believe that RYGB is a safe, effective procedure for most pa
tients with morbid obesity and thus may be the current procedure of choice
in patients requiring bariatric surgery for morbid obesity.